Skip to main content
Erschienen in: Abdominal Radiology 5/2019

19.02.2019 | Kidneys, Ureters, Bladder, Retroperitoneum

Diffusion tensor imaging of the kidney in healthy controls and in children and young adults with autosomal recessive polycystic kidney disease

verfasst von: Suraj D. Serai, Hansel J. Otero, Juan S. Calle-Toro, Jeffrey I. Berman, Kassa Darge, Erum A. Hartung

Erschienen in: Abdominal Radiology | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Abstract

Objective

To compare diffusion tensor imaging (DTI) of the kidneys and its derived parameters in children with autosomal recessive polycystic kidney disease (ARPKD) versus healthy controls.

Methods

In a prospective IRB-approved study, we evaluated the use of DTI to compare kidney parenchyma FA values in healthy controls (age-matched children with no history of renal disease) versus patients with ARPKD. A 20-direction DTI with b-values of b = 0 s/mm2 and b = 400 s/mm2 was used to acquire data in coronal direction using a fat-suppressed spin-echo echo-planar sequence. Diffusion Toolkit and TrackVis were used for analysis and segmentation. TrackVis was used to draw regions of interest (ROIs) covering the entire volume of the renal parenchyma, excluding the collecting system. Fibers were reconstructed using a deterministic fiber tracking algorithm. The FA values based on the ROI data, mean length, and volume of the tracks based on the fiber tracking data were recorded.

Results

Eight healthy controls (mean age = 12.9 years ± 4.0; 1/8 males) and six ARPKD participants (mean age = 13.8 years ± 8.5; 5/6 males) were included in the study. Compared to healthy controls, patients with ARPKD had significantly lower FA values (0.33 ± 0.03 vs. 0.25 ± 0.02, p = 0.002) and mean track length (16.73 ± 3.43 vs. 11.61 ± 1.29 mm, p = 0.005).

Conclusion

DTI of the kidneys shows significantly lower FA values and mean track length in children and young adults with ARPKD compared to normal subjects. DTI of the kidney offers a novel approach for characterizing renal disease based on changes in diffusion anisotropy and kidney structure.
Literatur
2.
Zurück zum Zitat Hartung, E.A. and L.M. Guay-Woodford, Autosomal recessive polycystic kidney disease: a hepatorenal fibrocystic disorder with pleiotropic effects. Pediatrics, 2014. 134(3): p. e833-45.CrossRefPubMedPubMedCentral Hartung, E.A. and L.M. Guay-Woodford, Autosomal recessive polycystic kidney disease: a hepatorenal fibrocystic disorder with pleiotropic effects. Pediatrics, 2014. 134(3): p. e833-45.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Guay-Woodford, L.M., et al., Consensus expert recommendations for the diagnosis and management of autosomal recessive polycystic kidney disease: report of an international conference. J Pediatr, 2014. 165(3): p. 611-7.CrossRefPubMedPubMedCentral Guay-Woodford, L.M., et al., Consensus expert recommendations for the diagnosis and management of autosomal recessive polycystic kidney disease: report of an international conference. J Pediatr, 2014. 165(3): p. 611-7.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Wang, X., et al., Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat. J Am Soc Nephrol, 2005. 16(4): p. 846-51.CrossRefPubMed Wang, X., et al., Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat. J Am Soc Nephrol, 2005. 16(4): p. 846-51.CrossRefPubMed
5.
Zurück zum Zitat Masyuk, T.V., et al., Pasireotide is more effective than octreotide in reducing hepatorenal cystogenesis in rodents with polycystic kidney and liver diseases. Hepatology, 2013. 58(1): p. 409-21.CrossRefPubMedPubMedCentral Masyuk, T.V., et al., Pasireotide is more effective than octreotide in reducing hepatorenal cystogenesis in rodents with polycystic kidney and liver diseases. Hepatology, 2013. 58(1): p. 409-21.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Sweeney, W.E., P. Frost, and E.D. Avner, Tesevatinib ameliorates progression of polycystic kidney disease in rodent models of autosomal recessive polycystic kidney disease. World J Nephrol, 2017. 6(4): p. 188-200.CrossRefPubMedPubMedCentral Sweeney, W.E., P. Frost, and E.D. Avner, Tesevatinib ameliorates progression of polycystic kidney disease in rodent models of autosomal recessive polycystic kidney disease. World J Nephrol, 2017. 6(4): p. 188-200.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Grantham, J.J., et al., Volume progression in polycystic kidney disease. N Engl J Med, 2006. 354(20): p. 2122-30.CrossRefPubMed Grantham, J.J., et al., Volume progression in polycystic kidney disease. N Engl J Med, 2006. 354(20): p. 2122-30.CrossRefPubMed
8.
Zurück zum Zitat Torres, V.E., et al., Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial. Nephrol Dial Transplant, 2018. 33(3): p. 477-489.CrossRefPubMed Torres, V.E., et al., Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial. Nephrol Dial Transplant, 2018. 33(3): p. 477-489.CrossRefPubMed
9.
Zurück zum Zitat Yu, A.S.L., et al., Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease. Kidney Int, 2018. 93(3): p. 691-699.CrossRefPubMed Yu, A.S.L., et al., Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease. Kidney Int, 2018. 93(3): p. 691-699.CrossRefPubMed
10.
Zurück zum Zitat Gunay-Aygun, M., et al., Correlation of kidney function, volume and imaging findings, and PKHD1 mutations in 73 patients with autosomal recessive polycystic kidney disease. Clin J Am Soc Nephrol, 2010. 5(6): p. 972-84.CrossRefPubMedPubMedCentral Gunay-Aygun, M., et al., Correlation of kidney function, volume and imaging findings, and PKHD1 mutations in 73 patients with autosomal recessive polycystic kidney disease. Clin J Am Soc Nephrol, 2010. 5(6): p. 972-84.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Jaimes, C., et al., Diffusion tensor imaging and tractography of the kidney in children: feasibility and preliminary experience. Pediatr Radiol, 2014. 44(1): p. 30-41.CrossRefPubMed Jaimes, C., et al., Diffusion tensor imaging and tractography of the kidney in children: feasibility and preliminary experience. Pediatr Radiol, 2014. 44(1): p. 30-41.CrossRefPubMed
12.
Zurück zum Zitat Bergmann, C., et al., Clinical consequences of PKHD1 mutations in 164 patients with autosomal-recessive polycystic kidney disease (ARPKD). Kidney Int, 2005. 67(3): p. 829-48.CrossRefPubMed Bergmann, C., et al., Clinical consequences of PKHD1 mutations in 164 patients with autosomal-recessive polycystic kidney disease (ARPKD). Kidney Int, 2005. 67(3): p. 829-48.CrossRefPubMed
13.
Zurück zum Zitat Hagmann, P., et al., Understanding diffusion MR imaging techniques: from scalar diffusion-weighted imaging to diffusion tensor imaging and beyond. Radiographics, 2006. 26 Suppl 1: p. S205-23.CrossRefPubMed Hagmann, P., et al., Understanding diffusion MR imaging techniques: from scalar diffusion-weighted imaging to diffusion tensor imaging and beyond. Radiographics, 2006. 26 Suppl 1: p. S205-23.CrossRefPubMed
14.
Zurück zum Zitat Kim, H.K., et al., Magnetic resonance imaging of pediatric muscular disorders: recent advances and clinical applications. Radiol Clin North Am, 2013. 51(4): p. 721-42.CrossRefPubMedPubMedCentral Kim, H.K., et al., Magnetic resonance imaging of pediatric muscular disorders: recent advances and clinical applications. Radiol Clin North Am, 2013. 51(4): p. 721-42.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Radhakrishnan, R., et al., Reduced Field of View Diffusion-Weighted Imaging in the Evaluation of Congenital Spine Malformations. J Neuroimaging, 2016. 26(3): p. 273-7.CrossRefPubMed Radhakrishnan, R., et al., Reduced Field of View Diffusion-Weighted Imaging in the Evaluation of Congenital Spine Malformations. J Neuroimaging, 2016. 26(3): p. 273-7.CrossRefPubMed
16.
Zurück zum Zitat Serai, S.D., et al., Putting it all together: established and emerging MRI techniques for detecting and measuring liver fibrosis. Pediatr Radiol, 2018. 48(9): p. 1256-1272.CrossRefPubMed Serai, S.D., et al., Putting it all together: established and emerging MRI techniques for detecting and measuring liver fibrosis. Pediatr Radiol, 2018. 48(9): p. 1256-1272.CrossRefPubMed
17.
Zurück zum Zitat Zhang, J.L., et al., New magnetic resonance imaging methods in nephrology. Kidney Int, 2014. 85(4): p. 768-78.CrossRefPubMed Zhang, J.L., et al., New magnetic resonance imaging methods in nephrology. Kidney Int, 2014. 85(4): p. 768-78.CrossRefPubMed
18.
Zurück zum Zitat Mori, S. and P.C. van Zijl, Fiber tracking: principles and strategies - a technical review. NMR Biomed, 2002. 15(7-8): p. 468-80.CrossRefPubMed Mori, S. and P.C. van Zijl, Fiber tracking: principles and strategies - a technical review. NMR Biomed, 2002. 15(7-8): p. 468-80.CrossRefPubMed
19.
Zurück zum Zitat Hueper, K., et al., Diffusion-Weighted imaging and diffusion tensor imaging detect delayed graft function and correlate with allograft fibrosis in patients early after kidney transplantation. J Magn Reson Imaging, 2016. 44(1): p. 112-21.CrossRefPubMed Hueper, K., et al., Diffusion-Weighted imaging and diffusion tensor imaging detect delayed graft function and correlate with allograft fibrosis in patients early after kidney transplantation. J Magn Reson Imaging, 2016. 44(1): p. 112-21.CrossRefPubMed
22.
Zurück zum Zitat Feng, Q., et al., DTI for the assessment of disease stage in patients with glomerulonephritis--correlation with renal histology. Eur Radiol, 2015. 25(1): p. 92-8.CrossRefPubMed Feng, Q., et al., DTI for the assessment of disease stage in patients with glomerulonephritis--correlation with renal histology. Eur Radiol, 2015. 25(1): p. 92-8.CrossRefPubMed
23.
Zurück zum Zitat Gaudiano, C., et al., Diffusion tensor imaging and tractography of the kidneys: assessment of chronic parenchymal diseases. Eur Radiol, 2013. 23(6): p. 1678-85.CrossRefPubMed Gaudiano, C., et al., Diffusion tensor imaging and tractography of the kidneys: assessment of chronic parenchymal diseases. Eur Radiol, 2013. 23(6): p. 1678-85.CrossRefPubMed
24.
Zurück zum Zitat Notohamiprodjo, M., et al., Diffusion tensor imaging of the kidney with parallel imaging: initial clinical experience. Invest Radiol, 2008. 43(10): p. 677-85.CrossRefPubMed Notohamiprodjo, M., et al., Diffusion tensor imaging of the kidney with parallel imaging: initial clinical experience. Invest Radiol, 2008. 43(10): p. 677-85.CrossRefPubMed
Metadaten
Titel
Diffusion tensor imaging of the kidney in healthy controls and in children and young adults with autosomal recessive polycystic kidney disease
verfasst von
Suraj D. Serai
Hansel J. Otero
Juan S. Calle-Toro
Jeffrey I. Berman
Kassa Darge
Erum A. Hartung
Publikationsdatum
19.02.2019
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 5/2019
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-019-01933-4

Weitere Artikel der Ausgabe 5/2019

Abdominal Radiology 5/2019 Zur Ausgabe

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.